Recurrent Cervical Cancer


National Gynecologic Cancer Awareness Month on CancerConnect (September 9, 2014)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of cervical, ovarian and uterine cancer educational programs for national gynecologic cancer awareness month.... Continue Reading

Avastin Improves Outcomes for Women with Advanced Cervical Cancer (June 10, 2013)

In a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic cervical cancer. These results were presented at the 2013... Continue Reading

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival... Continue Reading

January Is National Cervical Cancer Awareness Month (January 4, 2010)

As the month of January brings cervical cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options,... Continue Reading

Avastin® Shows Promise in Treatment of Cervical Cancer (March 2, 2009)

Avastin® Shows Promise in Treatment of Cervical Cancer According to the results of a Phase II clinical trial, the targeted therapy Avastin® (bevacizumab) warrants further investigation in the treatment... Continue Reading

January Is National Cervical Cancer Awareness Month (January 2, 2009)

As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading

Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers (March 17, 2008)

The administration of the blood cell growth factor Neulasta® (pegfilgrastim) on the first day of chemotherapy among women with gynecologic cancers may be as effective as and more convenient than second-day... Continue Reading

Cervical Cancer Survivors Face Long-term Risk of Second Cancers (November 1, 2007)

Cervical Cancer Survivors Face Long-term Risk of Second Cancers According to the results of a study published in the Journal of the National Cancer Institute, cervical cancer survivors have an increased... Continue Reading

Cervical Cancer Survivors Face Risk of Second Cancers (April 27, 2007)

Cervical Cancer Survivors Face Risk of Second Cancers According to the results of a study presented at the 2007 annual meeting of the American Association for Cancer Research (AACR), the risk of a second... Continue Reading

Possible Role for Avastin® in Recurrent Cervical Cancer (November 15, 2006)

Possible Role for Avastin® in Recurrent Cervical Cancer A small study of six patients suggests that the combination of Avastin® (bevacizumab) and chemotherapy may be a promising approach to the treatment... Continue Reading

Stress and Depression Frequent Among Women Treated for Gynecological Cancers (February 22, 2005)

Stress and Depression Frequent Among Women Treated for Gynecological Cancers According to the results of a study recently published in Gynecologic Oncology , women with gynecologic cancer often experience... Continue Reading

Addition of Taxol(R) to Cisplatin Improves Progression-Free Survival in Advanced Cervical Cancer (August 4, 2004)

Addition of Taxol® to Cisplatin Improves Progression-Free Survival in Advanced Cervical Cancer According to a recent article published in the Journal of Clinical Oncology, the addition of Taxol®... Continue Reading

Recurrent Cervical Cancer (March 22, 2004)

Overview When cervical cancer has been detected or has returned following initial treatment with surgery, radiation therapy and/or chemotherapy, it is said to be recurrent or relapsed. The course of treatment... Continue Reading

Cisplatin Plus Topotecan Improves Survival Compared to Cisplatin Alone in Recurrent Cervical Cancer (March 18, 2004)

Cisplatin Plus Topotecan Improves Survival Compared to Cisplatin Alone in Recurrent Cervical Cancer According to results presented at the 2004 annual meeting of the American Society of Gynecologic... Continue Reading

Paclitaxel Combined with Cisplatin Chemotherapy Appears More Effective than Cisplatin Therapy Alone for Treatment of Recurrent or Advanced Squamous Cell Carcinoma of the Cervix (February 9, 2002)

Paclitaxel Combined with Cisplatin Chemotherapy Appears More Effective than Cisplatin Therapy Alone for Treatment of Recurrent or Advanced Squamous Cell Carcinoma of the Cervix Based on the results... Continue Reading

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS